Martine A Rothblatt - Net Worth and Insider Trading
Martine A Rothblatt Net Worth
The estimated net worth of Martine A Rothblatt is at least $30,810 dollars as of 2024-04-25. Martine A Rothblatt is the CHAIRPERSON & CEO of United Therapeutics Corp and owns about 130 shares of United Therapeutics Corp (UTHR) stock worth over $30,810. Details can be seen in Martine A Rothblatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martine A Rothblatt has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Martine A Rothblatt
Martine A Rothblatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martine A Rothblatt owns 1 companies in total, including United Therapeutics Corp () .
Click here to see the complete history of Martine A Rothblatt’s form 4 insider trades.
Insider Ownership Summary of Martine A Rothblatt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| United Therapeutics Corp | 2024-04-08 | director & Chief Executive Officer |
Martine A Rothblatt Latest Holdings Summary
Martine A Rothblatt currently owns a total of 1 stock. Martine A Rothblatt owns 130 shares of United Therapeutics Corp (UTHR) as of April 22, 2024, with a value of $30,810.
Latest Holdings of Martine A Rothblatt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-04-22 | 130 | 237.00 | 30,810 |
Holding Weightings of Martine A Rothblatt
Martine A Rothblatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Martine A Rothblatt has made a total of 107 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 107 sells. The most-recent trade in United Therapeutics Corp is the sale of 7,200 shares on April 22, 2024, which brought Martine A Rothblatt around $2 Million.
Insider Trading History of Martine A Rothblatt
- 1
Martine A Rothblatt Trading Performance
GuruFocus tracks the stock performance after each of Martine A Rothblatt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martine A Rothblatt is 16.94%. GuruFocus also compares Martine A Rothblatt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martine A Rothblatt within 3 months outperforms 17 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martine A Rothblatt's insider trading performs compared to the benchmark.
Performance of Martine A Rothblatt
Average Return
40.64%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.91 | 16.94 | 10.72 | 40.64 | 39.83 | 41.51 |
| Relative Return to S&P 500(%) | 6.42 | 6.53 | 0.95 | 21.22 | 20.01 | 26 |
Martine A Rothblatt Ownership Network
Ownership Network List of Martine A Rothblatt
Ownership Network Relation of Martine A Rothblatt
Martine A Rothblatt Owned Company Details
What does United Therapeutics Corp do?
Who are the key executives at United Therapeutics Corp?
Martine A Rothblatt is the director & Chief Executive Officer of United Therapeutics Corp. Other key executives at United Therapeutics Corp include EVP & General Counsel Paul A Mahon , President and COO Michael Benkowitz , and director & President and COO Roger Jeffs .
United Therapeutics Corp () Insider Trades Summary
Over the past 18 months, Martine A Rothblatt made 77 insider transaction in United Therapeutics Corp () with a net sale of 1,318,085. Other recent insider transactions involving United Therapeutics Corp () include a net sale of 206,500 shares made by Paul A Mahon , a net sale of 1,977 shares made by Nilda Mesa , and a net sale of 7,760 shares made by Judy D. Olian .
In summary, during the past 3 months, insiders sold 435,090 shares of United Therapeutics Corp () in total and bought 0 shares, with a net sale of 435,090 shares. During the past 18 months, 1,554,802 shares of United Therapeutics Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,554,802 shares.
United Therapeutics Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
United Therapeutics Corp Insider Transactions
Martine A Rothblatt Mailing Address
Above is the net worth, insider trading, and ownership report for Martine A Rothblatt. Currently GuruFocus does not have mailing address information for Martine A Rothblatt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
